GHRH depolarizes the membrane of somatotropes, leading to an increase in intracellular free Ca 2؉ concentration and GH secretion. Na ؉ channels mediate the rapid depolarization during the initial phase of the action potential, and this regulates Ca 2؉ influx and GH secretion. GHRH increases a tetrodotoxinsensitive somatotrope Na ؉ current that is mediated by cAMP.
G
HRH PLAYS A MAJOR role in controlling GH secretion from somatotropes. It is generally accepted that GHRH depolarizes somatotropes, resulting in an increase in the intracellular free Ca 2ϩ concentration ([Ca 2ϩ ] i ) and GH secretion. GHRH action is mediated mainly through receptor coupled Gs proteins, an increase in cAMP, and activation of protein kinase A (PKA) (1) (2) (3) . The phospholipase C (PLC)-protein kinase C (PKC) signaling pathway also contributes to GH secretion (4, 5) . Three main cation selective channels, Na ϩ , Ca 2ϩ , and K ϩ , have been identified in somatotropes, and their activities determine depolarization and hyperpolarization in these cells. It has been shown that GHRH increases the current through voltage-gated Ca 2ϩ channels via the cAMP/PKA system. GHRH decreases the voltage-gated K ϩ current, involving the PKC system in primary cultured ovine and human somatotropes (6) . It has been suggested that GHRH increases Na ϩ permeability via cAMP, which leads to depolarization of the cell (7) (8) (9) and subsequent activation of voltage-gated Ca 2ϩ channels, facilitating Ca 2ϩ influx and increasing [Ca 2ϩ ] i . Voltage-gated Na ϩ channels have been observed in a variety of cells and are involved in regulating membrane electrical properties in excitable cells such as neurons and endocrine cells, including anterior pituitary cells (10 -13) . Voltage-gated Na ϩ channels can be classified into two main categories: 1) those that can be selectively blocked by low, nanomolar concentrations of tetrodotoxin (TTX), called TTX-sensitive (TTX-S) Na ϩ channels and 2) TTX-resistant (TTX-R) Na ϩ channels, which are blocked only by high, tens of micromolar concentrations of TTX (14, 15) . Nine subtypes of voltage-gated Na ϩ channels (Na v 1.1-1.9) have been identified and classified as a single family, based on their evolutionary relationships (14, 16) . Na v 1.1-1.4 and Na v 1.6 -1.7 are TTX-S, whereas Na v 1.5, -1.8, and -1.9 are TTX-R (17) (18) (19) . Na v 1.5 is mainly expressed in cardiac myocytes (20, 21) and has also been reported in neuroblastoma cells (22) and rat dorsal root ganglion (DRG) neurons (23) . Na v 1.8 and -1.9 are mainly expressed in DRG neurons (18, 24) . Na v 1.8 mediates a slowly inactivating current and plays an important role in the generation of action potentials (25) . Hyperexcitability results from an increase in the amplitude of TTX-R Na ϩ currents, and hyperexcitability is absent in DRG neurons of Na v 1.8 null mice (26) . Na v 1.9 mediates an ultraslow inactivation, or persistent, TTX-R current and may contribute to modulating the resting membrane potential, hence mediating excitability (19, 27) . The TTX-R Na ϩ current is well expressed and characterized in neurons but not in pituitary cells, especially somatotropes.
Kato and colleagues (7) have shown that GHRH increases [Ca 2ϩ ] i and GH secretion in rat somatotropes by mechanisms involving the cAMP/PKA messenger system. These effects were dependent on extracellular Na ϩ but are not blocked by 2 m TTX (low dose), which prompted these authors to suggest the involvement of Na ϩ channels that were resistant to TTX (5-7). This notion is supported by the observation that the rise in [Ca 2ϩ ] i was reduced by 40% when TTX was increased to 20 m (7). Kato (28) went on to show that GHRH increases the total voltage-gated Na ϩ current in somatotrope-enriched cells of rat pituitary. Interestingly, this current was entirely abolished by 2 m TTX. Only seven of 16 cells responded to GHRH, and whereas this may reflect the heterogeneous nature of the cell population, it also raises the possibility that not all somatotropes express voltage-gated channels equally. To ensure that only somatotropes were investigated in the present study, we used pituitaries from green fluorescent protein (GFP)-GH transgenic mice. Thus, with new technologies, including the recent characterization of Na v currents, we expanded the study to encompass probing the effects of PKC as well as cAMP/PKA transduction systems on TTX-R Na ϩ currents in somatotropes. We observed TTX-R Na ϩ currents using perforated whole-cell patch-clamp recordings in GFP-GH mice somatotropes. GHRH enhanced the TTX-R Na ϩ current through the PKC rather than through the PKA system.
Materials and Methods Chemicals
The following solutions and chemicals were used: culture medium (DMEM), HEPES, NaHCO 3 , fetal calf serum (Thermo Electron Corp., Melbourne, Australia); penicillin-streptomycin, Fungizone antibiotic solution, trypsin (Life Technologies, Inc., Gaithersburg, MD); GHRH (Auspep, Victoria, Australia); tetrodotoxin (Alomone Laboratory, Jerusalem, Israel); collagenase type I, deoxyribonuclease (DNase), hyaluronidase, trypsin inhibitor, pancreatin, tetraethylammonium ClϪ (TEA), CoCl 2 , nystatin, dimethyl sulfoxide (DMSO), all general salts (Sigma, St. Louis, MO); H89, KT 5720, Rp-cAMP, 8-bromoadenosine-cAMP (8-bromo-cAMP), forskolin, 3-isobutyl-1-methylxanthine (IBMX), U-73122, Gő6983, phorbol-12,13-dibutyrate (PDBu), and phorbol-12-myristate-13-acetate (PMA) (Calbiochem, San Diego, CA).
Cell preparation
Adult (10 -12 wk) GFP-GH transgenic mice were decapitated and pituitary glands were immediately collected into ice-cold PBS solution. All experiments were approved by the Animal Ethics Committee of Monash Medical Centre (Melbourne, Australia). The pituitaries were minced and placed in Ca 2ϩ -free PBS with 0.1% BSA. The tissue fragments were gently washed and incubated with DNase, hyaluronidase (1 mg/ml), trypsin inhibitor (0.5 mg/ml), pancreatin, and collagenase type I (ϳ1 mg/ml) for 15 min at 37 C in a shaking bath. The solution was filtered using a sterilized mesh filter and then centrifuged at 1500 rpm for 5 min. The cells were suspended in culture medium (90% DMEM ϩ 10% FCS ϩ 1% antibiotic) and plated into 35-mm culture dishes for electrophysiological study and growth hormone assay. Cells were grown in a humidified incubator (37 C, 5% CO 2 ), the culture medium was changed every 2 d, and electrophysiological recordings were performed after 4 -8 d of culture.
DNA analysis of transgenic animals
The analysis protocol has been described previously (28) . Briefly, genomic DNA from tail biopsies was analyzed for transgene DNA by standard PCR procedures using PCR primers: 5Ј-ACC ACT CAG GGT CCT GTG GAC AG-3Ј (sense), 5Ј-CCT CTT GAA GCC AGG GCA GGC AGA GCA GGC-3Ј (antisense). We used a denaturation step at 94 C for 1 min, an annealing step at 60 C for 30 sec, and an extension step at 72 C for 90 sec for a total of 35 cycles, followed by an additional extension step at 72 C for 10 min. Detection of PCR amplification products was carried out by electrophoresis on a 2% agarose gel containing ethidium bromide. The signal intensity of each band was determined using Quantity One 4.5 software (Bio-Rad Laboratories, Hercules, CA).
RNA isolation and RT-PCR
The total RNA from GFP-GH mice pituitary, heart, and DRG was isolated using the RNeasy minikit fitted with a built-in column (QIA-GEN, Hilden, Germany). RNA from heart and DRG were used as positive controls. Pituitary, heart, and DRG were removed immediately and frozen quickly with dry ice. RLT buffer/␤-mercapto was added to the tissues and homogenized using a fine needle. The homogenate was centrifuged for 3 min on maximum (ϳ15000 rpm) speed, and then an equal volume of 70% ethanol was added to the supernatant and mixed gently by pipetting. The sample was centrifuged using an RNeasy minicolumn/collection tube for 15 sec at about 10000 rpm. RW1 buffer was added to the RNeasy minicolumn/collection tube and centrifuged for 15 sec at about 10000 rpm. Five hundred microliters of RPE buffer were added to the minicolumn and centrifuged for 15 sec at about 10000 rpm followed by addition of another 500 l of RPE buffer and centrifuged for 2 min at about 10000 rpm. To elute the RNA, 30 l RNA-free water was applied to the minicolumn and centrifuged for 1 min at about 10000 rpm. Total RNA extracted from each tissue was treated with DNase I (Roche, Indianapolis, IN) to eliminate possible DNA contamination. RNA (1 g) from pituitary, heart, and DRG were then reverse transcribed to cDNA in a 20 l reverse transcription reaction system containing random primers and avian myeloblastosis virus-reverse transcription at 46 C for 2 h.
PCR primers for Na v 1.5, -1.8, and -1.9 were designed based on published sequences of Na v 1.5 (accession no. M77235 and M27902), Na v 1.8 (accession no. X92184 and Y09108), and Na v 1.9 (accession no. NM011887) (21) : for Na v 1.5, 5Ј-ACC AAC TGC GTG TTC ATG GCC CA-3Ј (sense), 5Ј-AGC ATG AAG AAG ATC ATG TAG ATC TT-3Ј (antisense) (760 bp); for Na v 1.8, 5Ј-GTG GAG CAC AGC TGG TTT GAG-3Ј (sense), 5Ј-AAC ACA TTC CAG CCG TTG GTG-3Ј (antisense) (1181 bp); for Na v 1.9, 5Ј-TGA TTC GCA TCT CTG TCC ATT C-3Ј (sense), 5Ј-CCC AAT GAA GAC GTA TTC GGG A-3Ј (antisense) (137 bp). mRNA derived from heart and DRG were used as positive controls. We used a denaturation step at 94 C for 1 min, an annealing step at 60 C for 30 sec, and an extension step at 72 C for 90 sec for a total of 35 cycles, followed by an additional extension step at 72 C for 10 min. Detection of PCR amplification products was carried out by electrophoresis on a 1.4% agarose gel containing ethidium bromide. The signal intensity of each band was determined using Quantity One 4.5 software (Bio-Rad Laboratories).
Electrophysiological recording
On the day of recording, the culture medium was replaced with patch-clamp bath solution at least 10 min before recording. Transmembrane Na ϩ currents were recorded using the patch-clamp technique in nystatin-perforated whole-cell recording (WCR) configuration. Electrodes were pulled on a P-87 microelectrode puller (Shutter Equipment Co., Navato, CA) from borosilicate glass with an inner filament (Harvard Apparatus Ltd., Edenbridge, UK). These electrodes had an initial input resistance of 4 -6 m⍀. All recording were made with the Axopatch-1 C amplifier (Axon Instruments, Foster City, CA).
The bath solution was composed of (in mm): TEA-Cl 40, NaCl 105, CaCl 2 3, MgCl 2 0.5, glucose 10, HEPES 10 (pH 7.4, adjusted with NaOH; osmolarity 310 mOsm/liter). To exclude contamination by Ca 2ϩ currents and TTX-S Na ϩ current, 3 mm Co 2ϩ and 1 m TTX were added to the bath solution.
The pipette solution consisted of (in mm): CsCl 55, Cs 2 SO 4 75, MgSO 4 8, and HEPES 10 (pH 7.4 and osmolarity 300 mOsm/liter), and the electrode was backfilled with this solution containing nystatin (250 g/ml in 0.1% DMSO). This concentration of DMSO, applied to cells in WCR configuration, had no effect on membrane conductance.
Culture dishes containing the cells were fixed on the stage of an Olympus inverted microscope (New Hyde Park, NY). The electrode was positioned using a micromanipulator (Narishige, Tokyo, Japan). After obtaining a high-resistance seal the pipette potential was held at Ϫ70 mV and voltage steps (10 mV, 200 msec duration) were delivered periodically to monitor the capacitance and access resistance. Access to the cell interior was judged by the appearance of a transient membrane capacitance current 2-5 min after forming a seal. Whole-cell capacitance and series resistance (using only cells with Ͻ35 m⍀) were compensated (Ͼ80%) before experimentation, and leak current was routinely subtracted using the Clampex 8.0 program (Axon Instruments). The change in series resistance over the course of each experiment was also monitored, and recordings with a greater than 20% change in series resistance were excluded from the final data analysis. The electrical signal was filtered at 2 kHz with a low-pass filter and the sweeps were sampled at 1 kHz in our recording protocols.
A gravity pressure system was used to change the bath solution. PKA-cAMP and PLC-PKC blockers/activators, including H-89, RpcAMP, 8-bromo cAMP, U73122, and PDBu, were added to the static bath by hand pipetting into the culture dish containing the cells. Control recordings were started at least 10 min after patching the cell. The effect of drug treatment was recorded until the response reached a plateau or until we were certain that no change was occurring. Application of vehicle did not change Na ϩ currents. All experiments were performed at room temperature (20 -22 C) .
Incubation experiment and mouse GH assay
After 4 d of culture in 48-well plates, each well contained approximately 30,000 cells. The cells were preincubated for 1.5 h with serum-free medium (DMEM ϩ 0.5% BSA). This medium was subsequently discarded and 250 l/well fresh incubation medium, with or without test substance, was applied for 45 min. The medium was collected and stored at Ϫ20 C for GH assay.
The GH concentration in the incubation medium was assayed using mouse GH-ELISA kit, DSL-10-72100 (Diagnostic Systems Laboratories Inc., Webster, TX). All samples were assayed in duplicate. All samples from one experiment were determined in the same assay, and four separate experiments were performed. GH values were expressed as nanogram equivalents of mouse GH standard.
Whole-cell current data analysis
Conductance was determined as I/(V-V R ), where I is the peak inward current at test pulse voltage V, and V R is the calculated reversal potential. Normalized conductance, I/I max ϭ 1/(1 ϩ exp[(V pp Ϫ V h )/k h ]), I/I max was fit with a single Boltzmann relationship of the form where V pp is the prepulse potential, V h is the midpoint potential, and k h is the slope factor. I-V curves were fitted by:
where a is a scaling factor with the dimension of conductance, V is the pulse potential, b is the potential for zero current, V a the half-activation voltage, and k a the corresponding slope factor.
Inactivation kinetics were evaluated by fitting the decay of the current with a single exponential for TTX-R Na ϩ current, according to the equation:
where A is amplitude, t is the interval in milliseconds, is the time constant, and C is the offset.
Data statistic analysis
The pCLAMP 8.0 software (Axon Instruments) was used to record and analyze the data. A 2 test was used to normalize value percent of control, and a paired t test was used to evaluate the statistical significance of differences between control and treated group means obtained from the same group of cells. Differences were accepted as significant at P Ͻ 0.05. Group data are expressed as mean Ϯ sem. The example traces displayed were chosen as representative of at least four recordings under the same experimental conditions, unless otherwise indicated in the text.
Results

TTX-R Na ϩ channel expression in GFP-GH transgenic mice pituitary
RT-PCR analysis showed that all three types of TTX-R Na ϩ current subtypes (Na v 1.5, -1.8, and -1.9) are expressed in cells from GFP-GH transgenic mice pituitaries. Na v 1.9 was more strongly expressed than Na v 1.5 or -1.8 (an example from one animal shown in Fig 1) . As a positive control, Na v 1.5 was expressed in heart and both Na v 1.8 and -1.9 were expressed in DRG, as previously shown (18, 20) . We confirmed that the PCR product did not come from DNA contamination by using RNA sample without reverse transcription (data not shown).
Characterization of total Na ϩ currents in GFP-GH mice somatotrope
In the presence of Ca 2ϩ and K ϩ channel blockers to isolate Na ϩ currents and using nystatin-perforated WCR configuration, voltage-gated Na ϩ currents were recorded in response to step depolarizations, in 10-mV increments, from Ϫ50 to ϩ40 mV from a holding potential of Ϫ70 mV. Application of 1 m TTX reduced the total Na ϩ current by half (Fig. 2Ab) . Increasing the concentration of TTX to 10 m was without additional effect on the residual remaining Na ϩ current (n ϭ 3, data not shown). To test that the remaining current was carried by Na ϩ , choline was used to substitute for Na ϩ in the bath solution. All the remaining current was abolished in Na ϩ -free solution (Fig. 2Ac) , suggesting the presence of significant contribution of TTX-R Na ϩ currents in somatotropes.
The maximum TTX-R current (in the presence of 1 m TTX) exhibited inactivation with a single-exponential decay, ϭ 1.23 Ϯ 0.06 msec (n ϭ 7) at 0 mV. The half-activation voltage of the TTX-R Na ϩ current curve was Ϫ26 Ϯ 1 mV (n ϭ 3). The current-voltage curve of the peak current was constructed. The maximal current occurred at around 0 mV in these cells and the mean (Ϯsem) values observed in five cells are shown in Fig. 2B .
Not every GFP-positive cell possessed a TTX-R Na ϩ current. 188 of 328 GFP-positive cells, about 60% of cells, expressed a TTX-R Na ϩ current. MrVIB (muO-conotoxin from Conus marmoreus), a blocker of Na v 1.8, had no effect on the TTX-R Na ϩ current in these somatotropes (n ϭ 3, data not shown).
Effect of GHRH on the voltage-gated Na ϩ current in mouse somatotropes
Application of GHRH (100 nm) significantly (P Ͻ 0.05) increased the total voltage-gated Na ϩ current by about 25% (Fig. 3) . All GFP-positive cells responded to GHRH. Next, the TTX-R component of the Na ϩ current was isolated using 1 m TTX, and GHRH (100 nm) also significantly increased this TTX-R Na ϩ current, by approximately 20% (Fig. 4Ab) . The effect was totally reversible within 10 -15 min after removal of GHRH (Fig. 4) . Mean (Ϯsem) values of the TTX-R Na ϩ current in five cells are shown in Fig. 4B , and increase in the Na ϩ current by GHRH was statistically significant (P Ͻ 0.05). GHRH did not affect the steady-state inactivation curve for the TTX-R Na ϩ current (Fig. 4D) . Figure 4D was well fitted by a Boltzmann relationship with V h ϭ Ϫ60 mV (TTX-R Na ϩ current) and Ϫ61 mV (GHRH).
The cAMP-PKC signal transduction system
In the presence of TTX (1 m), Co 2ϩ , and TEA to remove involvement of TTX-S Na ϩ , Ca 2ϩ , and K ϩ currents, various blockers and activators were used to probe the nature of the second-messenger system involved in the activation of the TTX-R Na ϩ current by GHRH. The cAMP-PKA system is an important established signaling pathway in the action of GHRH in somatotropes (29 -31) . A series of membrane permeable blockers of cAMP-PKA signaling system was used before and during application of GHRH and the effect on the TTX-R Na ϩ current from six cells are shown in Figs. 5 and 6. The PKA inhibitor H-89 (1 m) alone had no effect on the basal TTX-R Na ϩ current. In the presence of H-89, GHRH caused a significant (P Ͻ 0.05) increase in the TTX-R Na ϩ current that was not different from the increase observed in the absence of H89 (Fig. 5A) . GHRH also evoked the usual increase in the TTX-R Na ϩ current in the presence of KT5720 (100 nm), another PKA inhibitor ( Fig.  5B , P Ͻ 0.05). The competitive cAMP antagonist, Rp-cAMP (100 m), had no effect on the basal TTX-R Na ϩ current, and it also had no effect on the ability of GHRH to significantly increase this current ( Fig. 5C , P Ͻ 0.05).
Activation of cAMP-PKA using the plasma membrane permeant cAMP analog, 8-bromo-cAMP (100 m), alone significantly increased the TTX-R Na ϩ current, but additional application of GHRH evoked the usual further approximate 20% increase in the current ( Effect of GHRH on the TTX-R Na ϩ current. The voltage-gated TTX-R Na ϩ current in GFP-GH mice somatotropes was recorded from a holding potential of Ϫ70 mV. A, Data are from a representative cell in control solution (a), in the presence of GHRH (100 nM) (b), and after washout of GHRH (c). B, Mean (ϮSEM) TTX-R Na ϩ current amplitude measured during depolarizing steps to 0 mV (n ϭ 5, *, P Ͻ 0.05). C, Current-voltage relationship of TTX-R Na ϩ current, measured at the peak of each current trace, in the absence (ࡗ) and presence of GHRH (f), and after washout (OE). Current amplitudes are normalized to the peak Na ϩ current for each cell. Mean Ϯ SEM of six cells. D, Steady-state inactivation curves of TTX-R Na ϩ current in control solution (छ) and in the presence of GHRH (Ⅺ). A dual-step protocol was used in which a test step (200 msec) of 0 mV was preceded by step (100 msec) to different potentials, from Ϫ100 to Ϫ20 mV. The currents are normalized to the largest current and plotted against the prepulse voltages. Results are mean Ϯ SEM of four cells.
of GHRH increased the current further by the usual approximate 20% (Fig. 6B , P Ͻ 0.05). Also, application of forskolin ϩ IBMX in the presence of GHRH increased further the TTX-R Na ϩ current significantly ( Fig. 6C , P Ͻ 0.05). These results indicate that the effect of GHRH on the TTX-R Na ϩ current is not mediated by the cAMP-PKA signaling system.
The PLC-PKC signal transduction system
Another main signaling pathway used by GHRH is the PLC-PKC system (6). Application of U73122 (5 m), a PLC inhibitor, did not alter the basal TTX-R Na ϩ current, but it completely prevented the increase in current usually induced by GHRH (Fig. 7A) . Again, GHRH failed to increase Mean (Ϯ SEM, n ϭ 6) TTX-R Na ϩ current amplitude in response to depolarizing steps to 0 mV from a holding potential of Ϫ70 mV. GHRH-induced an increase in the TTX-R Na ϩ current in the presence of PKA blockers, H-89 (1 M) (A) and KT5270 (100 nM) (B) (*, P Ͻ 0.05). Application of GHRH in the presence of cAMP blocker, Rp-cAMP (100 M), significantly increased TTX-R Naϩ current (C) (*, P Ͻ 0.05). . 6 . Effect of GHRH in the presence of cAMP-PKA activators. Mean (Ϯ SEM, n ϭ 5 and 6) TTX-R Na ϩ current amplitude in response to depolarizing steps to 0 mV from a holding potential of Ϫ70 mV. A, 8-bromo cAMP (100 M), a cAMP activator, significantly increased the TTX-R Na ϩ current, which was further significantly increased by GHRH (A) (*, P Ͻ 0.05). Forskolin ϩ IBMX, AC (adenylyl cyclase) activator, increased TTX-R Na ϩ current significantly (B), and GHRH further increased the current (C). Conversely, stimulation with GHRH increased the Na ϩ current significantly, and forskolin ϩ IBMX evoked further stimulation (C) (*, P Ͻ 0.05).
the TTX-R Na ϩ current in the presence of Gő6983 (1 m), a PKC inhibitor (Fig. 7B) .
Activation of PKC using PDBu (0.5 m) induced a significant increase in the basal TTX-R Na ϩ current and prevented the ability of GHRH to further increase the current (Fig. 8A) . Whereas GHRH alone increased the Na ϩ current, addition of PDBu in the presence of GHRH did not further influence the current (Fig. 8B) . Another PKC activator, PMA (0.1 m), produced similar results to PDBu (Fig. 8C) . These results indicate that an intact PLC-PKC system is required for the GHRH-induced increase in the TTX-R Na ϩ current.
Effects of TTX and Na ϩ -free condition on GH secretion
We examined the effect of TTX and Na ϩ -free medium on basal and GHRH-induced GH secretion (Fig. 9) . TTX or Na ϩ -free medium alone significantly reduced basal GH secretion with same extent. GHRH doubled GH secretion above basal, and this was blocked by prior inclusion of TTX (1 m) or in the absence of Na ϩ in the medium, compared with control (Fig. 9A ). In the presence of TTX (1 m), GHRH still increased GH secretion significantly with a similar extent to control condition (Fig. 9, A and B) . This indicates that TTX-S Na ϩ current is mainly involved in basal GH secretion, but GHRH can still stimulate GH secretion; even this current is blocked by 1 m TTX. In Na ϩ -free solution, GHRH-induced GH release was markedly reduced with a much less extent to control condition (Fig. 9B) . This indicates an involvement of TTX-R Na ϩ channel in GHRH-stimulated GH secretion but not in basal GH secretion. Effect of GHRH in the presence of PLC-PKC inhibitors. Mean (ϮSEM; n ϭ 8 and 5) TTX-R Na ϩ current amplitude in response to depolarizing steps to 0 mV from a holding potential of Ϫ70 mV. A, U73122 (5 M), a PLC inhibitor, had no effect on the TTX-R Na ϩ current but prevented the ability of GHRH to increase the current. B, Likewise, Gő6983 (1 M), a PKC inhibitor, had no effect on the TTX-R Na ϩ current and prevented GHRH-induced stimulation. Mean (ϮSEM, n ϭ 4 and 6) TTX-R Na ϩ current amplitude in response to depolarizing steps to 0 mV from a holding potential of Ϫ70 mV. A, PDBu (0.5 M), a PKC activator, significantly increased the TTX-R Na ϩ current (*, P Ͻ 0.05), but GHRH in the presence of PDBu did not increase the current. B, GHRH alone increased the TTX-R Na ϩ current significantly (*, P Ͻ 0.05), but application of PDBu was without additional effect. C, PMA, a PKC activator, increased the Na ϩ current (*, P Ͻ 0.05), but there was no further increase on addition of GHRH.
Discussion
In the present study, we have demonstrated the existence of a TTX-R Na ϩ current in primary somatotropes of GFP-GH transgenic mice and show that GHRH significantly increased this current. The mechanism of GHRH action on the TTX-R Na ϩ current is through the PLC-PKC signaling pathway. The use of GFP-GH mice allowed us to identify the recorded cells as somatotropes, which is critically important for electrophysiological study. Blocking TTX-S Na ϩ channels reduced basal GH secretion, but no further change was observed with extra Na ϩ removal. However, GHRH-stimulated GH secretion was reduced by TTX without statistic significance but then abolished upon removal of extracellular Na ϩ (in TTX), demonstrating that TTX-R Na ϩ is indeed significantly involved in GHRH-stimulated GH secretion.
Voltage-gated Na ϩ channels are expressed in a variety of cells and they mediate the rapid increase in Na ϩ conductance during the initial phase of the action potential in many electrically excitable cells (32) . The increase in the voltage-gated Na ϩ current by GHRH in rat pituitary cell has been shown previously (28) , but there is no information on the specific class or type(s) of Na v channels involved in the response to GHRH. The TTX-S current has been identified in rat somatotropes and is involved in the regulation of GH secretion (33) . Indirect evidence has suggested an involvement of TTX-R Na ϩ channels in the stimulation of GH secretion by GHRH (31, 34) .
Previous studies suggested that TTX-R Na ϩ channel may be involved in basal GH release by altering [ (9) . In the present study, we have shown that GHRH increases the total Na ϩ current by about 25% in GFP-identified mouse somatotropes. Furthermore, by isolating the TTX-R Na ϩ current we have provided electrophysiological evidence for the existence of this component in mouse somatotropes. Here we used 1 m TTX, which blocks all TTX-S Na ϩ channels in most tissues (15) , although some suggest that cardiac TTX-S Na ϩ channels may require 10 TTX for complete blockade (35) . In the present study, 10 m TTX did not provide additional blockade over 1 m TTX. Na ϩ selectivity has been confirmed using choline substitution for Na ϩ . The contribution of TTX-S and TTX-R channels was roughly 50% each in these somatotropes. GHRH increased the TTX-R Na ϩ current by about 20% of control, which is similar to the extent of the increase in the total Na ϩ current. It seems, therefore, that GHRH increases both TTX-S and TTX-R components of the Na ϩ current. Because the TTX-S Na ϩ current has been studied extensively in pituitary endocrine cells (36 -38) , the present study focused on the TTX-R Na ϩ current. GHRH did not change the kinetics of the TTX-R Na ϩ current, both the current-voltage relationship and voltage-dependent inactivation remained identical. The effect of GHRH could be explained in terms of either an increase in the number of TTX-R Na ϩ channels that open or by an increase in single channel conductance.
All three subtypes of TTX-R Na ϩ channels, Na v 1.5, -1.8, and -1.9, are expressed in mouse pituitary gland (Fig. 1) . The caveat here is that somatotropes were not isolated and hence the Na v subtype in that cell population remains unclear. However, in the electrophysiological studies, we used a selective TTX-R Na v 1.8 channel subtype blocker, MrVIB (39) , in an attempt to resolve the issue further. MrVIB had no effect on the recorded Na ϩ current. Although MrVIB is effective in blocking neuronal Na v 1.8 channels, the structure and formation of subunits of channel in somatotropes may be slightly different. Na v 1.5 channels possess fast inactivating characteristics (40, 41) , whereas Na v 1.8 and -1.9 show slow or persistent inactivating characteristics, with generally longer than 4 msec (18, 19) . In our somatotropes the of inactivation of the TTX-R channel was fast (1.23 Ϯ 0.06 msec), similar to Na v 1.5 channels in other cell types. Whereas Na v 1.5 is the most sensitive of the TTX-R Na ϩ channel subtypes to TTX, being blocked in the high micromolar range (17, 23), we found that 10 m TTX was without additional effect on the TTX-R Na ϩ current. This suggests that the TTX-R Na ϩ current in mouse somatotropes may not go through Na v 1.5. The -free, P Ͻ 0.05) reduced basal GH secretion. GHRH (100 nM) increased GH secretion significantly (GHRH, P Ͻ 0.05), and this was markedly reduced by TTX (1 M) (TTX ϩ GHRH) and was prevented by excluding Na ϩ from the bathing solution (Na ϩ ϩ GHRH). B, GH secretion was reformatted, expressed as percent of the appropriate control value. GHRH (100 nM) significantly increased GH secretion (*, P Ͻ 0.05) in control solution or in the presence of TTX but not in Na ϩ -free solution.
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